I'm LongbridgeAI, I can summarize articles.Core Scientific (CORZ) closed the week at $13.10, down 2.82% from $13.48 the previous Friday. The S&P 500 slipped 0.47% over the same stretch, leaving CORZ about 2.35 percentage points behind the benchmark. The stock ran up early in the week—touching $14.49 on Wednesday—before giving back the gains, with a Thursday sell-off and a Friday close near the low of $12.94. The week’s range came to 11.1%.
The Week
Core Scientific (CORZ) closed the week at $13.10, down 2.82% from $13.48 the previous Friday. The S&P 500 slipped 0.47% over the same stretch, leaving CORZ about 2.35 percentage points behind the benchmark. The stock ran up early in the week—touching $14.49 on Wednesday—before giving back the gains, with a Thursday sell-off and a Friday close near the low of $12.94. The week’s range came to 11.1%.
Key Events
Company-specific news was light this week, with the narrative driven mainly by the wider AI infrastructure complex. On Monday, options-flow reports noted that CORZ had dropped 6% the previous Friday, with some put contracts up 49%. Whale alerts in information technology names followed on Tuesday. On Wednesday, Chief Legal and Administrative Officer Todd DuChene reported a disposal of about $230,995.81 in common shares. From Thursday into Friday, AI debt worries took over: short sellers were said to have pocketed around $6 billion across several neocloud names, CoreWeave tumbled after Bernstein cut its target on debt concerns, and CORZ slipped alongside peers even as pre-market trading on Friday briefly bounced. Separate commentary flagged that the stock still looked rich after a 32% slide from its peak.
Analyst Ratings
As of 23 October, 22 institutions cover Core Scientific: 17 rate it buy, 3 rate it overweight, 2 rate it hold, with no underweight or sell ratings. The consensus rating is strong buy, and the consensus target price sits at $31.48, about 140.3% above the latest price of $13.10. Targets range widely from $16.00 to $47.00, pointing to meaningful dispersion across brokers. Within the application software industry, CORZ ranks 26th out of 208 names for analyst preference.
The Week Ahead
No company-specific release is due in the next few days, with the next major event being Core Scientific’s third-quarter FY2026 results before the open on 5 November; consensus looks for an EPS of roughly -$0.0441 and revenue near $194m. The macro calendar in between is busy, with durable goods orders, FHFA and Case Shiller home price data, new home sales, and consumer confidence all due on Tuesday. Those prints could shape expectations around AI capex durability and feed back into sentiment for AI infrastructure names including CORZ.
In Short
The setup this week is a tug of war: broker ratings remain constructive, with 17 buy and 3 overweight calls and a consensus target well above spot, while the latest session’s flow showed large-lot buying but softer small-lot participation, and AI debt and valuation concerns dominated the back half of the week. The next test is the 5 November report, alongside macro data that may shift the market’s view on AI spending momentum.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.